Načítá se...
T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity
PURPOSE: Successful tumor eradication primarily depends on generation and maintenance of a large population of tumor-reactive CD8 T cells. Dendritic cells (DCs) are well-known potent antigen-presenting cells and have applied to clinics as potent antitumor therapeutic agents. However, high cost and d...
Uloženo v:
| Vydáno v: | Cancer Res Treat |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Cancer Association
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373873/ https://ncbi.nlm.nih.gov/pubmed/32065848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.721 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|